Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Dec;10(23):1280. doi: 10.21037/atm-22-5444

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

2022 Annals of Translational Medicine. All rights reserved.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0.

PMC Copyright notice

High expression of TMED2/3/4/9 indicated the immune-suppressive status in breast cancer. (A) Analysis of the relationship between the expressions of immune checkpoint genes and TMED2/3/4/9 mRNA levels was performed by the Sangerbox webtool. (B) GO enrichment analysis of the top 200 co-expressed genes of TMED2/3/4/9 generated by Metascape. (C) The interactome network of TMED2/3/4/9 and their common immune-related genes predicted by GeneMANIA database. *, P<0.05; **, P<0.01; ***, P<0.001. TMED, transmembrane p24 trafficking protein; BRCA, breast carcinoma; mRNA, messenger RNA; GO, Gene Ontology.